Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where do you see that? I just looked on yahoo and it says they are at 43%
News on Monday - is my Friday afternoon prognostication
Let the run up begin!!!
Lets drop a PR on some vaccine collaboration with delivery device.
I’ve done some due diligence on ZSAN - love their micro needle delivery technology and the FDA approval next month for the migraine med with delivery technology appears to look very positive.
Glad to see that name on your list.
BUT - if a court was going to take a case En Banc then the date or order taking the case En Banc would be known and uploaded to PACER...right?
For an En Banc to happen - would we not see something in PACER prior to OA?
Ouch - offering
So we have AZN and now ACST all failed trials in this space -
Amazing - so obvious what we are doing ...right <deep sigh>
VASCEPA Generic Drug Name = Veino
The Liquid Stent
“tough on plaque - safe on veins”
EVAPORATE RESULTS = LIQUID STENT
There were significant differences between icosapent ethyl and placebo at study end for secondary endpoints of other types of plaque volume changes, including and sequentially total, total non-calcified, fibrofatty, and fibrous plaque volumes. All regressed in the icosapent ethyl group and progressed in the placebo group, (p<0.01 for all).
No chance R2G
EVAPORATE COUNT DOWN
NOTE: CEST TIME ZONE IS 6 hours ahead of EST.....so we presentation will be at 2:50 am tomorrow ??
Final results of the EVAPORATE Study August 29, 8:50-9:20 a.m. CEST
So - OA will commence and they will figure out what to do with the other later.
GREAT QUESTION
ORDER filed denying [10] [11] the motion, and the above-captioned appeal is stayed
I read this to state the appeal is paused pending clarification to the this?
BINGO
EVAPORATE read out getting closer
MOA will now be known and proven
Session: Late-Breaking Science in Lipids
“Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides on Statin Therapy: Final results of the EVAPORATE Study” – presented on behalf of all authors by Matthew Budoff, M.D., The Lundquist Institute – August 29, 8:50-9:20 a.m. CEST (Central European Summer Time)
Low volume spike this am - interesting
Double digits soon
Maybe today then
This gets approved today!!! 50-100% spike?
Product Details for ANDA 209499
ICOSAPENT ETHYL (ICOSAPENT ETHYL)
1GM
Marketing Status: Prescription
Active Ingredient: ICOSAPENT ETHYL
Proprietary Name: ICOSAPENT ETHYL
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 1GM
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209499
Product Number: 001
Approval Date: Aug 7, 2020
Applicant Holder Full Name: DR REDDYS LABORATORIES INC
Marketing Status: Prescription
only 54 million shares outstanding and tiny 84 million market cap
When this runs it’s going to go fast.
Get this in the hands of the appellate judges Clerks!
Get this in the hands of the appellate judges!
Here is link
https://t.co/mwAnp18OQ6
[pitchfork in hand emoticon]
90 day’ish low....Awesome
Great Trend
Hikma and Dr.Reddy thanks us all ....deep sigh
Come on appellate court - give us a much needed surprise
We received 2.789 million in first quarter I thought.
How much revenue do we expect from Canada this quarter? Could we see $10 million from rev share?
35 calendar days to OA
If that is true - quarter numbers should be solid with positive bottom line
Cash on hand should be going up - as DTC campaign was on hold last quarter.
"The CADTH recommendation to separate the diabetic population in two and exclude high-risk patients is perplexing to us as it is not rooted in good clinical practices and evidence-based medicine," said Mr. Gubitz.
Canada really drop diabetes from coverage????